Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Boxer

Showing results (131-140 of 184) with videos related to

Pageof 19
Sort By:
The Journal of Biological Chemistry|May 18, 1999
p53 suppresses the activation of the Bcl-2 promoter by the Brn-3a POU family transcription factorV Budhram-Mahadeo, P J Morris, M D Smith, et al.
International Journal of Radiation Oncology, Biology, Physics|February 16, 1999
A novel technique, using radioluminography, for the measurement of uniformity of radiolabelled antibody distribution in a colorectal cancer xenograft modelA A Flynn, A J Green, G M Boxer, et al.
Journal of Inherited Metabolic Disease|March 30, 2011
Pulmonary vascular disease in Gaucher disease: clinical spectrum, determinants of phenotype and long-term outcomes of therapySarah Michelman Lo, Jun Liu, F Chen, et al.
Journal of the American College of Cardiology|October 1, 1995
Family history of severe cardiovascular disease in Marfan syndrome is associated with increased aortic diameter and decreased survivalD I Silverman, J Gray, M J Roman, et al.
European Journal of Cancer (Oxford, England : 1990)|December 16, 1998
Exemplifying guidelines for preparation of recombinant DNA products in phase I trials in cancer: preparation of a genetically engineered anti-CEA single chain Fv antibodyA Mayer, K A Chester, J Bhatia, et al.
Biochemical Pharmacology|October 26, 1995
Genetic analysis of microsomal epoxide hydrolase in patients with carbamazepine hypersensitivityV J Green, M Pirmohamed, N R Kitteringham, et al.
Cancer Research|July 15, 1996
Ablation of colorectal xenografts with combined radioimmunotherapy and tumor blood flow-modifying agentsR B Pedley, J A Boden, R Boden, et al.
Cancer Research|April 28, 2001
A strategy for antitumor vascular therapy by targeting the vascular endothelial growth factor: receptor complexS P Cooke, G M Boxer, L Lawrence, et al.
British Journal of Cancer|March 1, 1987
A cytotoxic DNA precursor is taken up selectively by human cancer xenograftsK D Bagshawe, J Boden, G M Boxer, et al.
International Journal of Radiation Biology|April 17, 2001
Effectiveness of radiolabelled antibodies for radio-immunotherapy in a colorectal xenograft model: a comparative study using the linear--quadratic formulationA A Flynn, R B Pedley, A J Green, et al.
Pageof 19

Showing results (131-140 of 184) with videos related to

Sort By:
Pageof 19
The Journal of Biological Chemistry|May 18, 1999
p53 suppresses the activation of the Bcl-2 promoter by the Brn-3a POU family transcription factorV Budhram-Mahadeo, P J Morris, M D Smith, et al.
International Journal of Radiation Oncology, Biology, Physics|February 16, 1999
A novel technique, using radioluminography, for the measurement of uniformity of radiolabelled antibody distribution in a colorectal cancer xenograft modelA A Flynn, A J Green, G M Boxer, et al.
Journal of Inherited Metabolic Disease|March 30, 2011
Pulmonary vascular disease in Gaucher disease: clinical spectrum, determinants of phenotype and long-term outcomes of therapySarah Michelman Lo, Jun Liu, F Chen, et al.
Journal of the American College of Cardiology|October 1, 1995
Family history of severe cardiovascular disease in Marfan syndrome is associated with increased aortic diameter and decreased survivalD I Silverman, J Gray, M J Roman, et al.
European Journal of Cancer (Oxford, England : 1990)|December 16, 1998
Exemplifying guidelines for preparation of recombinant DNA products in phase I trials in cancer: preparation of a genetically engineered anti-CEA single chain Fv antibodyA Mayer, K A Chester, J Bhatia, et al.
Biochemical Pharmacology|October 26, 1995
Genetic analysis of microsomal epoxide hydrolase in patients with carbamazepine hypersensitivityV J Green, M Pirmohamed, N R Kitteringham, et al.
Cancer Research|July 15, 1996
Ablation of colorectal xenografts with combined radioimmunotherapy and tumor blood flow-modifying agentsR B Pedley, J A Boden, R Boden, et al.
Cancer Research|April 28, 2001
A strategy for antitumor vascular therapy by targeting the vascular endothelial growth factor: receptor complexS P Cooke, G M Boxer, L Lawrence, et al.
British Journal of Cancer|March 1, 1987
A cytotoxic DNA precursor is taken up selectively by human cancer xenograftsK D Bagshawe, J Boden, G M Boxer, et al.
International Journal of Radiation Biology|April 17, 2001
Effectiveness of radiolabelled antibodies for radio-immunotherapy in a colorectal xenograft model: a comparative study using the linear--quadratic formulationA A Flynn, R B Pedley, A J Green, et al.
Pageof 19